GlobeNewswire Inc.··NaIN8bio to Unveil Gamma-Delta T Cell Advances at May R&D Day
IN8bio showcases gamma-delta T cell advances and glioblastoma survival data at May 2026 R&D Day and major medical conferences.
INABclinical dataautoimmune diseases
I
$INAB
3 articles found2 positive
0 negative
1 neutral
GlobeNewswire Inc.··NaGlobeNewswire Inc.··NaIN8bio Grants Stock Options to New Employees Under Nasdaq Inducement Rules
IN8bio issued 11,800 stock options to two new employees on April 1, 2026, as hiring incentives under Nasdaq listing regulations.
INABautoimmune diseasescancer treatment
GlobeNewswire Inc.··Paulina DvorINB.bio Eyes $9.8T Wellness Boom With Aggressive 2026 Expansion Into Africa, MENA
INB.bio launches 2026 expansion strategy targeting Tanzania and 3-5 new countries across Africa and Southeast Asia, leveraging projected $9.8 trillion global wellness market.
INABemerging marketsSoutheast Asia